Ireland Technology News API

{
    "totalArticles": 112897,
    "articles": [
        {
            "title": "Space Force's Secret Plane Returns After More Than a Year in Orbit",
            "description": "The X-37B is a reusable robotic space plane operated by the US Space Force.",
            "content": "The X-37B is a reusable robotic space plane operated by the US Space Force. It resembles a miniature space shuttle at just under 9 metres long with a 4.5 metre wingspan and is an uncrewed vehicle designed for long-duration missions in low Earth orbit... [2448 chars]",
            "url": "https://www.sciencealert.com/space-forces-secret-plane-returns-after-more-than-a-year-in-orbit",
            "image": "https://www.sciencealert.com/images/2025/03/nasa_space_plane_header.jpg",
            "publishedAt": "2025-03-12T04:24:35Z",
            "source": {
                "name": "ScienceAlert",
                "url": "https://www.sciencealert.com"
            }
        },
        {
            "title": "March Patch Tuesday fixes 6 Windows zero-day exploits",
            "description": "March Patch Tuesday corrects 57 total vulnerabilities with the vast majority in the Windows OS.",
            "content": "While Microsoft corrected just 57 unique vulnerabilities this month, admins who manage Windows shouldn't relax until they apply patches for six known zero-day exploits for that OS.\nWhile the number of vulnerabilities is not large, admins have many fl... [4395 chars]",
            "url": "https://www.techtarget.com/searchwindowsserver/news/366620391/March-Patch-Tuesday-fixes-6-Windows-zero-day-exploits",
            "image": "https://www.techtarget.com/rms/onlineimages/ransom_g1264284948_01.jpg",
            "publishedAt": "2025-03-12T02:06:22Z",
            "source": {
                "name": "TechTarget",
                "url": "https://www.techtarget.com"
            }
        },
        {
            "title": "Tirzepatide helps people without diabetes lose 13% body weight in real-world study",
            "description": "A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at least six months lost an average of 12.9% of their body weight. The study highlights Tirzepatide’s potential as an effective off-label obesity treatment before its formal FDA approval for weight loss.",
            "content": "In one of the first real-world studies, Tirzepatide shows impressive weight loss results for people without diabetes—shedding nearly 13% of body weight in just six months.\nStudy: Real-world use and effectiveness of tirzepatide among people without ev... [7646 chars]",
            "url": "https://www.news-medical.net/news/20250311/Tirzepatide-helps-people-without-diabetes-lose-1325-body-weight-in-real-world-study.aspx",
            "image": "https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_804555_17417462380173490.jpg",
            "publishedAt": "2025-03-12T01:58:00Z",
            "source": {
                "name": "News-Medical.Net",
                "url": "https://www.news-medical.net"
            }
        }
    ]
}